O'Rourke & Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,146
| Closed | -$864K | – | 144 |
|
|
2024
Q1 | $864K | Sell |
20,146
-2,894
| -13% | -$124K | 0.5% | 45 |
|
|
2023
Q4 | $854K | Hold |
23,040
| – | – | 0.55% | 42 |
|
|
2023
Q3 | $835K | Sell |
23,040
-4,316
| -16% | -$156K | 0.61% | 38 |
|
|
2023
Q2 | $975K | Hold |
27,356
| – | – | 0.68% | 32 |
|
|
2023
Q1 | $973K | Hold |
27,356
| – | – | 0.74% | 32 |
|
|
2022
Q4 | $961K | Buy |
27,356
+1,104
| +4% | +$38.8K | 0.76% | 34 |
|
|
2022
Q3 | $773K | Buy |
26,252
+3,242
| +14% | +$95.5K | 0.67% | 39 |
|
|
2022
Q2 | $1.25M | Buy |
23,010
+262
| +1% | +$14.3K | 1.06% | 25 |
|
|
2022
Q1 | $1.24M | Buy |
22,748
+1,660
| +8% | +$90.4K | 0.85% | 29 |
|
|
2021
Q4 | $1.16M | Buy |
+21,088
| New | +$1.16M | 0.77% | 31 |
|